Precision medicine

Unlearn leverages digital twin models to simulate how participants may respond to treatments, according to CEO Steve Herne. This approach streamlines clinical trials by enhancing data precision and improving the quality of outcomes.

Amprion CEO Russ Lebovitz says proteins in the brain can misfold and form particles that spread from cell to cell, triggering neurodegenerative diseases. A test can identify these proteins, allowing for early diagnosis before symptoms appear.

The alliance combines ConcertAI's data platform with Bayer's scientific and AI expertise.

The funding round brings the company's total raise to $1.86 billion since it launched in 2018.

The projects will make use of genome sequencing data for more personalized, preventative and cost-effective healthcare.

Researchers claim their invention offers a cost-effective and faster way to do single-cell analysis.  

The aim of the partnership is to research how AI can help predict cancer progression.

Also, fitness technology company GOQii has introduced an AI-powered post-organ transplant care programme.

Around two in five Malaysians are said to have metabolic syndrome. 

Also, Indian diagnostics chain Redcliffe Labs has rolled out a mobile diabetes risk calculation feature.